Pfizer Wants Dozens Tossed From Bextra MDL

Law360, New York (August 23, 2010, 1:01 PM EDT) -- Pfizer Inc. has asked a court to dismiss the claims of dozens of plaintiffs in the multidistrict litigation over the arthritis drugs Celebrex and Bextra, alleging the plaintiffs have repeatedly failed to provide evidence that they ever took the drugs.

In a motion filed Friday in the U.S. District Court for the Northern District of California, Pfizer argues that about 90 of the hundreds of plaintiffs remaining in the case after an $894 million settlement in 2008 have not complied with court orders requiring them to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.